1. Home
  2. SOS vs EVGN Comparison

SOS vs EVGN Comparison

Compare SOS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOS Limited

SOS

SOS Limited

HOLD

Current Price

$1.39

Market Cap

10.7M

Sector

Finance

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.08

Market Cap

10.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOS
EVGN
Founded
2004
1999
Country
China
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Agricultural Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
10.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SOS
EVGN
Price
$1.39
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
43.6K
47.7K
Earning Date
09-26-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$260,505,000.00
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.35
P/E Ratio
N/A
N/A
Revenue Growth
134.43
7.19
52 Week Low
$1.02
$0.95
52 Week High
$9.62
$2.42

Technical Indicators

Market Signals
Indicator
SOS
EVGN
Relative Strength Index (RSI) 50.59 43.17
Support Level $1.29 $1.07
Resistance Level $1.56 $1.12
Average True Range (ATR) 0.11 0.05
MACD 0.04 0.00
Stochastic Oscillator 65.56 42.11

Price Performance

Historical Comparison
SOS
EVGN

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: